2.50
Lisata Therapeutics Inc Azioni (LSTA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
0.07
|
- | 1.00 | - | - |
|
15.55%
4.938
|
5.847 | 5.949 | 5.336 | 5.523 |
Benefits Costs and Expenses |
16.83%
4.729
|
5.686 | - | - | - |
Costs And Expenses |
16.83%
4.729
|
5.686 | - | - | - |
Depreciation and Amortization |
2.33%
0.044
|
0.043 | 0.041 | 0.042 | 0.045 |
Operating Income/Loss |
16.74%
-4.868
|
-5.847 | -4.949 | -5.336 | -5.523 |
Nonoperating Income/Loss |
29.81%
0.209
|
0.161 | 0.339 | 0.406 | 0.479 |
Income/Loss From Equity Method Investments |
-
|
- | - | -0.03 | - |
Income/Loss From Continuing Operations Before Tax |
18.06%
-4.659
|
-5.686 | -4.61 | -4.93 | -5.044 |
Income Tax Expense/Benefit |
100.00%
-
|
-0.962 | - | - | - |
Income/Loss From Continuing Operations After Tax |
1.38%
-4.659
|
-4.724 | -4.61 | -4.93 | -5.044 |
|
1.38%
-4.659
|
-4.724 | -4.61 | -4.93 | -5.044 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.03%
8.605
|
8.602 | 0.022 | 8.321 | 8.308 |
Diluted Average Shares |
0.03%
8.605
|
8.602 | 0.022 | 8.321 | 8.308 |
Basic Earnings Per Share |
1.82%
-0.54
|
-0.55 | -0.55 | -0.59 | -0.61 |
Diluted Earnings Per Share |
1.82%
-0.54
|
-0.55 | -0.55 | -0.59 | -0.61 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):